TB vaccine: latest news

TB vaccine resources

  • Vaccination

    For HIV-negative people there is a live vaccine against tuberculosis known as the Bacille Calmette-Guerin (BCG) vaccine, although its effectiveness appears to vary in different...

    From: HIV treatments directory

    Information level Level 4
  • Preventing TB

    Until 2005, school children in the UK and most other European countries were given a vaccination against TB, called BCG. However, this vaccination does not...

    From: Booklets

    Information level Level 2

TB vaccine in your own words

TB vaccine news from aidsmap

More news

TB vaccine news selected from other sources

  • First results of tuberculosis vaccine candidate MTBVAC very promising

    A phase I safety study of TB vaccine candidate MTBVAC, the first live-attenuated Mycobacterium  tuberculosis-based vaccine to enter clinical trials, shows very good results in the first intermediate analysis.

    18 November 2013 | TuBerculosis Vaccine Initiative
  • TB vaccine business case: lifesaving TB vaccines feasible

    The global tuberculosis (TB) epidemic annually causes 1.4 million deaths and is estimated to cost the global economy €290 billion per year. Vaccines that could prevent people from acquiring, developing and transmitting disease would be the single most effective tool in mitigating this epidemic. Making new TB vaccines available to the world over the next 10-15 years is estimated to cost approximately €600 million, utilizing a highly efficient portfolio approach and adequate funding.

    12 June 2013 | Tuberculosis Vaccine Initiative
  • Global scientific experts convene in Cape Town to report on progress toward tuberculosis vaccines

    At a time of growing global concern about the rising level of drug-resistant strains of tuberculosis in South Africa and worldwide, the world's top TB vaccine experts are meeting this week, the first time this scientific forum has been held in Africa, where they will present new research aimed at advancing development of vaccines against the deadly airborne disease.

    25 March 2013 | Eurekalert Inf Dis
  • Injection-free vaccination technique could address global vaccine challenge for diseases such as HIV and malaria

    Scientists at King’s College London have demonstrated the ability to deliver a dried live vaccine to the skin without a traditional needle, and shown for the first time that this technique is powerful enough to enable specialised immune cells in the skin to kick-start the immunising properties of the vaccine.

    11 February 2013 | Kings College London press release
  • Data from Historic Phase IIb Clinical Trial for Tuberculosis Vaccine Candidate MVA85A Published in The Lancet

    Vaccine candidate did not provide statistically-significant protection in preventing TB disease in infants previously vaccinated with BCG.

    04 February 2013 | Aeras
  • TB Vaccine Safe but Does Not Confer Protection, Calls for Redoubling Efforts on Global TB Vaccine Portfolio

    The clinical trial of the TB vaccine candidate MVA85A was a Phase IIb safety and efficacy trial in 2,797 infants living in the Western Cape province of South Africa. The candidate was safe and well tolerated in the population tested.

    04 February 2013 | Aeras
  • Revived search for a TB vaccine may be about to pay off

    After nearly 100 years, researchers could be on the verge of finding a vaccine that would eradicate tuberculosis infections, a scourge that kills 1.4 million people a year.

    04 February 2013 | Reuters
  • HEALTH: New TB vaccine on the horizon

    A research team at Oxford University in the UK is very close to determining the efficacy of their new tuberculosis (TB) vaccine. If current clinical trials are successful, it will be the first new TB vaccine in almost a century.

    17 October 2012 | IRIN Plus News
  • HEALTH: New TB vaccine on the horizon

    A research team at Oxford University in the UK is very close to determining the efficacy of their new tuberculosis (TB) vaccine. If current clinical trials are successful, it will be the first new TB vaccine in almost a century.

    17 October 2012 | IRIN
  • Green light for start clinical trials of innovative and promising tuberculosis vaccine

    European scientists are one step closer to delivering a new, safe and more effective vaccine against tuberculosis. Swiss-medic, the Swiss regulatory authority for medicine has given permission to start assessing the new TB vaccine in healthy adult volunteers. The vaccine, called MTBVAC, is the first vaccine of its kind to start clinical evaluation.

    17 October 2012 | TB vaccine Initiative
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.